Details of the Drug

General Information of Drug (ID: DMRQGMZ)

Drug Name

HD-003

Synonyms

NZ-419; Selective hydroxy radical modulator (chronic kidney disease), Hyundai/ Nippon Zoki

Indication

Disease Entry	ICD 11	Status	REF
Kidney disease	GC2Z	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D Structure is Not Available

3D MOL

2D MOL

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Hydroxy radical elimination (HYRE)	TT20DOQ	NOUNIPROTAC	Modulator	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT02378194) Change From Baseline to Chronic Kidney Disease Patient Before and After Administration Drug. U.S. National Institutes of Health.
2	Creatinine and HMH (5-hydroxy-1-methylhydantoin, NZ-419) as intrinsic hydroxyl radical scavengers. Drug Discov Ther. 2011 Aug;5(4):162-75.